| Jul 1 |
Merus names Fabian Zohren as chief medical officer
|
| Jul 1 |
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
|
| Jun 3 |
Merus’ MCLA-129 Demonstrates Promising Single-Agent Efficiency in METex14 NSCLC in Poster Presentation at the 2024 ASCO® Annual Meeting
|
| Jun 2 |
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
|
| May 30 |
Merus announces pricing of upsized public offering of common shares
|
| May 30 |
Merus Announces Pricing of Upsized Public Offering of Common Shares
|
| May 29 |
These Analysts Think Merus N.V.'s (NASDAQ:MRUS) Sales Are Under Threat
|
| May 29 |
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
|
| May 28 |
Merus announces proposed public offering of common shares
|
| May 28 |
Merus N.V. Announces Proposed Public Offering of Common Shares
|
